Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion type Assertion NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_head.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion description "[Thirty-six of 59 patients (61.0%) with esophageal cancer had detectable levels of methylated DAPK or APC promoter DNA and preoperative detection was significantly associated with an unfavorable prognosis as revealed by multivariate Cox proportional hazards regression analysis [Exp(b) = 4.578; P = 0.01].]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_provenance.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion evidence source_evidence_literature NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_provenance.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion SIO_000772 19259700 NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_provenance.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion wasDerivedFrom befree-20150227 NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_provenance.
- NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_assertion wasGeneratedBy ECO_0000203 NP241041.RAB2UaVuVY4AmE7CYWjo8qaN_xMHCOx2FzB96SDP_ZCrc130_provenance.